A Safety and Efficacy Trial of Stannsoporfin in Neonates With Hyperbilirubinemia
Condition(s):Hyperbilirubinemia, NeonatalLast Updated:October 30, 2019Terminated
Hide Studies Not Open or Pending
Condition(s):Hyperbilirubinemia, NeonatalLast Updated:October 30, 2019Terminated
Condition(s):Hyperbilirubinemia, NeonatalLast Updated:February 2, 2021Completed
Condition(s):Hyperbilirubinemia, Neonatal IndirectLast Updated:September 22, 2023Completed
Condition(s):Hyperbilirubinemia, NeonatalLast Updated:November 1, 2021Recruiting
Condition(s):Newborn; Vitality; Hyperbilirubinemia, NeonatalLast Updated:March 22, 2024Recruiting
Condition(s):Neonatal HyperbilirubinemiaLast Updated:January 29, 2024Completed
Condition(s):Neonatal HyperbilirubinemiaLast Updated:June 5, 2014Unknown status
Condition(s):Neonatal HyperbilirubinemiaLast Updated:March 11, 2021Completed
Condition(s):Neonatal HyperbilirubinemiaLast Updated:November 11, 2015Unknown status
Condition(s):Neonatal HyperbilirubinemiaLast Updated:November 11, 2011Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.